Exploring the Past to Inform the Future to Optimize the Pharmacokinetics of Vancomycin in Children With Severe Burn Injuries
Journal of Burn Care & Research · 2023
DOI: 10.1093/jbcr/irac147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Burn Care & Research, 2023. Verfasst von Catherine M Sherwin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Pediatrics, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA. Hauptthemen laut MEDLINE: Burns, Sepsis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: The Shriners Hospitals for Children®.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Sepsis remains one of the leading causes of death among pediatric patients with burn injuries. Despite limited vancomycin pharmacokinetic (PK) information within this population, it is widely used to treat severe burn injuries. Those with severe burns are at risk of nephrotoxicity, with an incidence of acute kidney injury (AKI) over 50%. Delivering an effective vancomycin dose and avoiding unnecessary toxicity is essential for improved patient outcomes. This was a retrospective analysis of 115 children aged 0.2 months to 18 years with severe burns, >10% total body surface area. Vancomycin was given via intravenous infusion; blood samples were drawn between 6- and 12-hour postinfusion. A population pharmacokinetic model was developed using nonlinear mixed-effect modeling (Monolix, version 2016R1). A one-compartment model described a steady-state volume of distribution (V), dependent on weight. Vancomycin clearance (CL) was influenced by age and estimated creatinine clearance (CrCL). The study population’s (median age = 4 years, median weight = 20 kg, median total body surface area (%TBSA) = 40%) median V and CL were calculated to be 1.25 L/kg (95% CI, 1.04–1.46) and 0.15 L/h/kg (95% CI, 0.126–0.165), respectively. The PK model was explicitly developed to characterize the impact of physiological changes in children under 18 years of age and the percentage of the burn surface area using limited data. The analysis determined that weight, age, and estimated CrCL were important covariates in predicting vancomycin PK with high variability in CL and V.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dept of Pediatrics, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.
- Dayton Children's Hospital, Dayton, OhH, USA.
- James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA.
- Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
- Department of Pathology and Laboratory Medicine, University of California, School of Medicine, Davis, CA, USA.
- University of Tennessee Medical Center and College of Pharmacy, Knoxville, TN, USA.
ORCID-Profile: Catherine M Sherwin
Förderung
- The Shriners Hospitals for Children®
Zitieren
APA
Sherwin, C. M., Tran, N. K., Sullivan, K., Wead, S., Birnbaum, A. K., Avachat, C., Healy, D. P., & Kagan, R. J. (2023). Exploring the Past to Inform the Future to Optimize the Pharmacokinetics of Vancomycin in Children With Severe Burn Injuries. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/irac147
Vancouver
Sherwin CM, Tran NK, Sullivan K, Wead S, Birnbaum AK, Avachat C, et al. Exploring the Past to Inform the Future to Optimize the Pharmacokinetics of Vancomycin in Children With Severe Burn Injuries. Journal of Burn Care & Research. 2023. doi:10.1093/jbcr/irac147
BibTeX
@article{Sherwin2023,
author = {Sherwin, Catherine M and Tran, Nam K and Sullivan, Kevin and Wead, Stephanie and Birnbaum, Angela K and Avachat, Charul and Healy, Daniel P and Kagan, Richard J},
title = {Exploring the Past to Inform the Future to Optimize the Pharmacokinetics of Vancomycin in Children With Severe Burn Injuries},
journal = {Journal of Burn Care & Research},
year = {2023},
doi = {10.1093/jbcr/irac147}
}
EUVIMED